Data Integrity: FDA/EU Requirements and Implementation

Cart

Contains 0 items
Total: $0.00
View Shopping Cart

Toll Free:
+1-888-717-2436

Data integrity has been a focus for pharmaceutical regulatory inspections for a number of years and look set to remain of concern to regulators and manufacturers for many years to come. Many inspection reports from regulatory agencies around the world cite data integrity as a cause of observations and enforcement action, and actions taken by regulators to restrict the commercial activities of manufacturers on the grounds of data integrity violations have obvious serious consequences for the company concerned.

This 2-day on-line course explains the background to the data integrity regulations and sets out the expectations of pharmaceutical regulators. All the current data integrity guidances emphasise a risk-based approach to compliance, and the course explains how to evaluate and control data integrity risks. A key resource in relation to electronic records is GAMP 5, which deals with controlling risk and managing computerised systems over their life cycle. The practices recommended by GAMP 5 will be dealt with in detail, and practical advice on the appropriate use of Excel spreadsheets given. Data integrity should not be thought of as an exclusively analytical problem, and examples of data integrity violations in production will highlight the risks during manufacturing.

Learning Objectives:

Attendees will:

Understand what data integrity is and why it is so important for patient safety
Recognise that there are many causes of data integrity breaches
Know the current regulatory expectations
Appreciate the difference between static and dynamic records, and be able to apply acceptable strategies for the retention of both types of record
Be able to categorise and validate GxP computerised systems according to GAMP 5
Understand the importance of training and quality culture in avoiding regulatory enforcement action
Learn how to respond to data integrity observations in inspection reports
Learn how to prevent, detect and remedy data integrity problems

Who will Benefit:

QA managers and personnel
Laboratory managers and supervisors
Production managers and supervisors
Analysts
IT/IS managers and system administrators
Software developers
Regulatory affairs
Training departments
Documentation departments
Consultants
Auditors

Companies and departments:

Pharmaceutical development and Quality control laboratories
API manufacturers
Medical device companies
Contract laboratories
Clinical research organisations
Suppliers and service providers of instruments and computer systems

In-Person Seminar going Virtual with increased learner satisfaction.

Yes, attend this seminar from anywhere. We are making it real and more interactive – Here's a sneak peek:

Our enhanced delivery process and technology provides you an immersive experience and will allow you to access:

The real-time and live presentation as in in-person events
Private chat for company-specific conversation – the same as you would get in an in-person seminar
Opportunities to connect with your peers to share knowledge at a different time and have group discussions
Live workshop activities
Live Q&A during the event and offline Q&A assistance after the event
As usual more content, activities and case studies and now adding homework for a comprehensive understanding
Certification

Download Brochure

Day 01(9:00 AM - 5:00 PM EDT)

09.00 AM: Session Start
Day 1 – Lectures and Workshop Exercises
Module 1: Historical background and data integrity definitions
- Data integrity and patient safety/product efficacy
- The evolution of GxP regulations – driven by both criminal activity and honest mistakes
- The US FDA’s debarment policy
- Evolution of data integrity guidances
- Introduction to GAMP 5
- Early data integrity cases
Module 2: Regulatory expectations
- ALCOA and ALCOA+
- Static and dynamic records
- Essential elements of data governance
- Non-conformance trends
- Data integrity controls
- Data integrity risks in sample analysis and production
- Investigating data integrity problems
- Metadata, audit trails and audit trail review
Module 3: Data integrity risk assessment
- Quality risk management: ICH Q9
- Risk management process
- Approaching a data integrity risk assessment
- Controlling risk in computerised systems
- Configuration and life cycle management
- Operating system and application software considerations
Module 4: Computerised systems
- Audit trails, access controls and user permissions
- Excel spreadsheets
- Introduction to computerised data system validation
Module 5: Day 1 conclusions
- Extracts from regulatory enforcement letters
- Addressing data integrity problems

Day 02(9:00 AM - 5:00 PM EDT)

Day 2 - Lectures and Workshop Exercises
Module 6: Managing computerised data systems
- Guidance
  - 21 CFR Part 11
  - EU Annex 11
  - GAMP 5
- Life cycle management and risk assessment
- Supplier assessment
Module 7: Computerised system validation
- Validation planning
  - Policy
  - Plans
  - Documentation
- System description
- Introduction to software testing
Module 8: Conducting a data integrity audit
- Planning the audit
- Conducting the audit
  - Policies, procedures, practices
  - Training
  - Quality culture
- Evaluating quality risk
- Mitigating data integrity risks
Module 9: Managing client audits and regulatory inspections
- The importance of data integrity risk assessments/action plans
- The audit/inspection process
- Client audits
  - Confidentiality
  - Result checking and reporting
- Regulatory inspections
  - Behaviour during inspection
  - Responding to non-conformance observations

Mark Powell
Director, Mark Powell Scientific Limited

Dr Mark Powell is a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as an analytical chemist. Mark was Honorary Treasurer of the RSC’s Analytical Division and led a working group on continuing professional development until July 2016, when his term of office ended. Between 2003 and 2013, he was the Analytical Development Manager, and later Scientific Manager, of a UK-based contract research organization which specialized in early-stage oral drug development. During this time, he was responsible for method validation, verification and transfer activities, as well as the qualification of laboratory instruments and computerized data systems. In 2013, he set up Mark Powell Scientific Limited, which provides training and consultancy services to pharmaceutical companies. Mark has since enjoyed working with companies of all sizes around the world on a variety of training and consultancy assignments, and has recently co-authored a White Paper on Pharmaceutical Data Integrity for the laboratory supply company VWR.

Register Now

1
July 9-10, 2020
Virtual Seminar

Online using Credit card

$1,899.00

(One Dial-in One Attendee)

July 9-10, 2020, Virtual Seminar

$9,685.00

Group-Max. 10 Attendees

July 9-10, 2020, Virtual Seminar

Other Registration Option

By order form / PO#

Download the Order Form
Fill this form with attendee details & payment details
Fax it to +1-650-362-2367, or
Email it to customercare@complianceonline.com

Payment Mode

By Check -

Pay your check to (payee name) “MetricStream Inc” our parent company and Mail the check to:

ComplianceOnline (MetricStream, Inc),
2479 E. Bayshore Road Suite 260
Palo Alto, CA 94303
USA

By Wire -

Please contact us at +1-888-717-2436 to get details of wire transfer option.

Note: In view of Coronavirus situation and travel advisory issued, ComplianceOnline will waive off all cancellation charges for the registrations till June 30, 2020.

Terms & Conditions to Register for the Seminar/Conference/Event

Your registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-717-2436 or email us @ customercare@complianceonline.com

Payment:

Payment is required 2 days before the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. (our parent company).

Cancellations and substitutions for In-person Seminars:

Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund - less a $300 administration fee. No cancellations will be accepted - nor refunds issued - within 10 calendar days before the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future ComplianceOnline event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite, payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available, we will send the material after the conference is over.

In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Cancellations and Substitutions for Virtual Seminars & Webinars:

Written cancellations through fax or email (from the person who has registered for the training) received at least 10 calendar days prior to the start date of the event will receive a refund — less a 30% administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days from the start date of the event. On request by email or fax (before the training) a credit for the amount paid minus administration fees (30%) will be transferred to any future ComplianceOnline event and a credit note will be issued. Substitutions may be made at any time. No-shows will be charged the full amount. Some topics and speakers may be subject to change without notice.

Offers:

Early bird seats are limited and based on first-come, first-serve.

Multiple offers cannot be combined.